APOLIPOPROTEIN E PHENOTYPE IN DEMENTED PATIENTS IN GREEK POPULATION

REFERENCES

• Al-Kedhairy A. A. A. Apolipoprotein E polymorphism as a predictor for cognitive decline and dementia in the Saudi general population over 65 years. Genetics & Molecular Biology 2004; 27(3)331–334
   Google Scholar
• Baloyannis S. J. The acoustic cortex in vascular dementia: A Golgi and electron microscopy study. Journal of Neurological Sciences 2005; 229–230: 51–55
   PubMedGoogle Scholar
• Baloyannis S. J. Mitochondrial alterations in Alzheimer's disease. Journal of Alzheimer's Disease 2006; 9: 119–126
   PubMed Web of Science ®Google Scholar
• Bullido M. J., Artiga M. J., Recuero M., Sastre I., Garcia M. A., Aldudo J., Lendon C., Han S. W., Morris J. C., Frank A., Vazquez J., Goate A., Valdivieso F. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nature Genetics 1998; 18(1)69–71
   PubMedGoogle Scholar
• Carrieri G., Bonafe M., De Luca M., Rose G., Varcasia O., Bruni A., Nacmias B., Sorbi S., Corsonello F., Feraco E., Andreev K. F., Yashin A. I., Franceschi C., De Benedictis G. Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease. Human Genetics 2001; 108(3)194–198
   PubMedGoogle Scholar
• Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of ApoE type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921–923
   PubMed Web of Science ®Google Scholar
• Czapiga M., Colton C. A. Microglial function in human ApoE3 and ApoE4 transgenic mice: Altered arginine transport. Journal of Neuroimmunology 2003; 134: 214–251
   Google Scholar
• Dergunov A. D., Novoselov A. V., Visvikis S., Siest G., Yakushkin V. V., Tsibulsky V. The composition, structural properties and binding of very low density and low-density lipoproteins to the LDL-Receptor in normo- and hypertriglycerinhemia: Relation to the apolipoprotein E phenotype. Biological Chemistry 2005; 386: 441–452
   PubMedGoogle Scholar
• Engelborghs S., Dermaut B., Goeman J., Saerens J., Mariën P., Pickut B. A., Van de Broeck M., Serneels S., Cruts M., Van Broeckhoven C., De Deyn P. P. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. Journal of Neurology, Neurosurgery and Psychiatry 2003; 74: 1148–1151
   PubMedGoogle Scholar
• Frank A., Díez-Tejedor E., Bullido M. J., Valdivieso F., Barreiro P. APOE Phenotype in cerebrovascular disease and vascular dementia. Journal of the Neurological Sciences 2002; 203–204: 173–176
   PubMedGoogle Scholar
• Gilliam F. G., Kanner A. M., Sheline Y. I. Depression and brain dysfunction. Taylor and Francis, BasingstokeUK 2005
   Google Scholar
• Glöckner F., Meske V., Ohm T. G. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease. Neurosciences 2002; 114(4)1103–1114
   PubMedGoogle Scholar
• Heijmans B. T., Slagboom P. E., Gussekloo J., Droog S., Lagaay A. M., Kluft C., Knook D. L., Westendorp R. G. Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age. American Journal of Medical Genetics 2002; 107(3)201–208
   PubMedGoogle Scholar
• Hofman A., Ott A., Breteler M. M., Bots M. L., Slooter A. J., van Harskamp F., van Duijn C. N., Van Broeckhoven C., Grobbee D. E. Atherosclerosis, apolipoprotein E and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997; 349(9059)1174
   Google Scholar
• Huang W., Qiu C., Von Strauss E., Fratiglioni L. APOE genotype, family history of dementia and Alzheimer disease risk. Archives of Neurology 2004; 61: 1930–1934
   PubMed Web of Science ®Google Scholar
• Huang X., Chen P., Kaufer D. I., Tröster A. I, Poole C. Apolipoprotein E and dementia in Parkinson disease. Archives of Neurology 2006; 63: 189–193
   PubMed Web of Science ®Google Scholar
• Ji Y., Gong Y., Gan W., Beach T., Holtzman D. M., Wisniewski T. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and AD patients. Neuroscience 2003; 122: 305–315
   PubMedGoogle Scholar
• Koch H. J., Gürtler K., Szecsey A. Correlation of MMSE, SKT and Clock Test Scores in patients with mild and moderate dementia. Nagoya Journal of Medical Science 2005; 67: 93–100
   PubMedGoogle Scholar
• Lai C. L., Tai C. T., Lin S. R., Lin R. T., Yang Y. H., Liu C. K. Apolipoprotein E in Taiwan Chinese patients with dementia. Dementia and Geriatric Cognitive Disorders 2003; 16: 208–211
   PubMedGoogle Scholar
• Marzanski M. On telling the truth to patients with dementia. Western Journal of Medicine 2000; 173(5)318–323
   PubMedGoogle Scholar
• McCarron M. O., Nicoll J. A. R. Apolipoprotein E Genotype and Cerebral Amyloid Angiopathy-related hemorrhage. Annals of the New York Academy of Sciences 2000; 903: 176–179
   PubMed Web of Science ®Google Scholar
• Morris J. C. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 1993; 43: 2412–2414
   PubMed Web of Science ®Google Scholar
• Polvikoski T., Sulkava R., Haltia M., Kainulainen K., Vuorio A., Verkkoniemi A., Niinistö L., Halonen P., Kontula K. Apolipoprotein E, dementia, and cortical deposition of β-Amyloid protein. The New England Journal of Medicine 1995; 333(19)1242–1248
   PubMed Web of Science ®Google Scholar
• Qiu C., Kivipelto M., Agüero-Torres H., Winblad B., Fratiglioni L. Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: Variation by age and sex. Journal of Neurology Neurosurgery and Psychiatry 2004; 75: 828–833
   PubMed Web of Science ®Google Scholar
• Richey P. L., Siedlak S. L., Smith M. A., Perry G. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: Implications for disease pathogenesis. Biochemical & Biophysical Research Communications 1995; 208: 657–663
   PubMedGoogle Scholar
• Santacruz K. S., Swagerty D. Early diagnosis of dementia. American Family Physician 2001; 63(4)703–713
   PubMed Web of Science ®Google Scholar
• Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L. M., Salvesen G., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., Rose A. D. Binding of human apolipoprotein E to synthetic amyloid-beta peptide: Isoform-specific affects and implications for late-onset Alzheimer disease. Proceedings of the National Academy of Sciences of USA 1993a; 90(17)8098–8102
   PubMed Web of Science ®Google Scholar
• Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: High avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences of USA 1993b; 90(5)1977–1981
   PubMed Web of Science ®Google Scholar
• Zurutuza L., Verpillat P., Raux G., Hannequin D., Puel M., Belliard S., Michon A., Pothin Y., Camuzat A., Penet C., Martin C., Brice A., Campion D., Clerget-Darpoux F., Frebourg T. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population. European Journal of Human Genetics 2000; 8(9)713–716
   PubMedGoogle Scholar